The Form 4 filing, an SEC report of insider stock trades and shares owned, was filed on November 18, 2026. The sales took place from November 16 through November 18.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-16 |
| Date of Latest Transaction | 2026-11-18 |
| Buy/Sell | sell |
| Transaction Count | 11 |
| Shares Transacted | 286,985 |
| Price | $95.21 |
| Total Transaction Value | $27,322,986.06 |
| Insider | |
| Ticker Symbol | CSCO |
| Company | CISCO SYSTEMS, INC. |
| Insider Name | Robbins Charles |
| Insider Title | Chair and CEO |
| Sector - Industry | Technology - Communication Equipment |
| Holdings | |
| Total Shares Owned After Transaction | 669,193.88 |
| Position Size Change | 30.01% |
| Filing | |
| Filing Date | 2026-11-18 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported under transaction code S. Charles Robbins, Cisco's chair and CEO, sold CSCO shares in 11 transactions. The available details do not identify how or where the shares were sold.
What was the average price of the transaction?
The average sale price was $95.21 per share across the 11 transactions. Prices for the individual sales are not available.
How did this transaction affect the insider's holdings?
Charles Robbins sold 286,985 shares and reported 669,193.88 shares owned afterward. The shares sold made up 30.01% of his reported shares held before the sales.
What's the total transaction value?
The 11 sales totaled $27,322,986.06, rounded to cents. This total covers all 286,985 shares sold across the transactions.
Are there any special circumstances around this transaction?
The transaction information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text is unavailable, so it is unclear whether the reference applies to the whole filing or only certain trades. It does not confirm which of the 11 sales the plan covered. The plan's start date, trading schedule, and other terms are unknown.
For research purposes only; not investment advice.